Skip to main content
AXSM logo
AXSM
(NASDAQ)
Axsome Therapeutics, Inc.
$255.17-- (--)
Loading... - Market loading

Axsome Therapeutics (AXSM) Stock Price & Financial Analysis

Axsome Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$253.04 - $257.93
52-Week High$257.44
52-Week Low$96.09
Open$253.04
Volume441.61K
Average Volume (3M)838.85K
Market Cap12.61B
Shares Outstanding51.20M
Price to Sales (P/S)17.81
Price to Book (P/B)231.05
EV/EBITDA-76.26
Revenue (TTM)708.24M
Net Income (TTM)-188.30M
Free Cash Flow (TTM)-70.99M
EPS (TTM)$-3.74
Profit Margin-26.59%
Operating Margin-22.93%
Return on Equity (ROE)-344.96%
Debt to Equity3.44
50-Day MA$209.80
200-Day MA$164.86
52-Week Change134.80%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Axsome Therapeutics

What is the current stock price for AXSM?

As of the latest trading session, AXSM stock trades at $255.17. The 52-week range is $96.09–$257.44, with a day range of $253.04–$257.93.

What is the P/E ratio for AXSM?

The P/E ratio (Price-to-Earnings) for AXSM is shown in the Key Statistics section. This valuation metric helps compare Axsome Therapeutics, Inc. to industry peers.

Does AXSM pay dividends?

Axsome Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AXSM?

Based on 6 analysts, the consensus for AXSM is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AXSM?

Axsome Therapeutics's market capitalization is $13.06B, classifying it as a large-cap company..